ATE157370T1 - Oligonukleotide mit wirkung gegen das respiratorische synzytial virus - Google Patents

Oligonukleotide mit wirkung gegen das respiratorische synzytial virus

Info

Publication number
ATE157370T1
ATE157370T1 AT95911046T AT95911046T ATE157370T1 AT E157370 T1 ATE157370 T1 AT E157370T1 AT 95911046 T AT95911046 T AT 95911046T AT 95911046 T AT95911046 T AT 95911046T AT E157370 T1 ATE157370 T1 AT E157370T1
Authority
AT
Austria
Prior art keywords
oligonucleotides
respiratory
virus
synzytial
active against
Prior art date
Application number
AT95911046T
Other languages
English (en)
Inventor
Robert E Kilkuskie
Patrick E Brown-Vargas
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Application granted granted Critical
Publication of ATE157370T1 publication Critical patent/ATE157370T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT95911046T 1994-02-18 1995-02-17 Oligonukleotide mit wirkung gegen das respiratorische synzytial virus ATE157370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19950394A 1994-02-18 1994-02-18

Publications (1)

Publication Number Publication Date
ATE157370T1 true ATE157370T1 (de) 1997-09-15

Family

ID=22737804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95911046T ATE157370T1 (de) 1994-02-18 1995-02-17 Oligonukleotide mit wirkung gegen das respiratorische synzytial virus

Country Status (7)

Country Link
EP (1) EP0745090B1 (de)
JP (1) JPH09509181A (de)
AT (1) ATE157370T1 (de)
AU (1) AU1878895A (de)
CA (1) CA2181546A1 (de)
DE (1) DE69500618D1 (de)
WO (1) WO1995022553A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014792A2 (en) * 1995-10-17 1997-04-24 Hybridon, Inc. Oligonucleotides with anti-respiratory syncytial virus activity
US6214805B1 (en) 1996-02-15 2001-04-10 The United States Of America As Represented By The Department Of Health And Human Services RNase L activators and antisense oligonucleotides effective to treat RSV infections
CA2246503A1 (en) * 1996-02-15 1997-08-21 National Institutes Of Health Rnase l activators and antisense oligonucleotides effective to treat rsv infections
US6958239B2 (en) 1996-11-21 2005-10-25 Oligos Etc Inc. Three component chimeric antisense oligonucleotides
US5831069A (en) * 1997-03-04 1998-11-03 South Alabama Medical Science Foundation Antisense oligonucleotides against nonstructural proteins NS1 and NS2 of respiratory syncytial virus and uses thereof
WO2003062258A1 (en) * 2002-01-22 2003-07-31 The Cleveland Clinic Foundation Rnase l activator-antisense complexes
EP3415625A1 (de) 2002-02-01 2018-12-19 Life Technologies Corporation Doppelsträngige oligonukleotide
CN104975020B (zh) 2008-02-11 2020-01-17 菲奥医药公司 经修饰的RNAi多核苷酸及其用途
US10138485B2 (en) 2008-09-22 2018-11-27 Rxi Pharmaceuticals Corporation Neutral nanotransporters
WO2010090762A1 (en) 2009-02-04 2010-08-12 Rxi Pharmaceuticals Corporation Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
AU2011232365A1 (en) 2010-03-24 2012-10-25 Rxi Pharmaceuticals Corporation RNA interference in dermal and fibrotic indications
US9095504B2 (en) 2010-03-24 2015-08-04 Rxi Pharmaceuticals Corporation RNA interference in ocular indications
EP3077050B1 (de) 2013-12-04 2020-10-21 Phio Pharmaceuticals Corp. Verfahren zur behandlung von wundheilung mit chemisch modifizierten oligonukleotiden
WO2016037071A2 (en) 2014-09-05 2016-03-10 Rxi Pharmaceuticals Corporation Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1
US10808247B2 (en) 2015-07-06 2020-10-20 Phio Pharmaceuticals Corp. Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
WO2017007813A1 (en) 2015-07-06 2017-01-12 Rxi Pharmaceuticals Corporation Nucleic acid molecules targeting superoxide dismutase 1 (sod1)
WO2017070151A1 (en) 2015-10-19 2017-04-27 Rxi Pharmaceuticals Corporation Reduced size self-delivering nucleic acid compounds targeting long non-coding rna
WO2022103671A1 (en) * 2020-11-12 2022-05-19 Merck Sharp & Dohme Corp. Anti-respiratory syncytial virus (rsv) antibody cell-based potency assay

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.

Also Published As

Publication number Publication date
EP0745090A1 (de) 1996-12-04
JPH09509181A (ja) 1997-09-16
AU1878895A (en) 1995-09-04
EP0745090B1 (de) 1997-08-27
DE69500618D1 (de) 1997-10-02
CA2181546A1 (en) 1995-08-24
WO1995022553A1 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
ATE157370T1 (de) Oligonukleotide mit wirkung gegen das respiratorische synzytial virus
TWI317735B (en) Methods and compositions for treating hepatitis c virus
BR9811260A (pt) Pequenas moléculas úteis no tratamento de doença inflamatória
WO2003063771A3 (en) N4-acylcytosine nucleosides for treatment of viral iinfections
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
NO954217L (no) Guanosinrike antivirus-oligonukleotider
WO2001032153A3 (en) Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
WO2001068116A3 (en) Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
WO1999052515A3 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
FI953515A (fi) Fluoksetiinin farmaseuttiset formulaatiot
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
CA2380924A1 (en) Compositions for treating viral infections, and methods therefor
EP0328924A3 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
ZA991029B (en) Composition and methods for treatment of hiv infections.
WO2000038660A3 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
NO931246L (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
WO1997014792A3 (en) Oligonucleotides with anti-respiratory syncytial virus activity
NO953321D0 (no) 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler
FR2693202B1 (fr) Polymères amphiphiles hydrosolubles, leur procédé de préparation et leur application comme épaississant.
MY124071A (en) Treatment of viral disease in swine
WO2001029054A3 (en) Medicaments for treatment of respiratory syncytial virus infections
WO2001045642A3 (en) Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties